Mutations of the BRAF gene in human cancer

Helen Davies1, Graham R Bignell, Charles Cox

  • 1Cancer Genome Project, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, CB10 1SA, UK.

Nature
|June 18, 2002
PubMed

Insights

BRAF mutations are common in melanoma and other cancers. These BRAF gene mutations lead to increased kinase activity, driving cancer cell growth and suggesting new therapeutic targets for melanoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer develops from accumulated gene mutations affecting cell growth and death.
  • Signaling pathways with mutated genes in human cancers are prioritized for study.
  • The RAS RAF MEK ERK MAP kinase pathway regulates cellular responses to growth signals.

Purpose of the Study:

  • To identify genes within signaling pathways mutated in human cancers.
  • To investigate the frequency and impact of BRAF mutations in various cancers, particularly melanoma.

Main Methods:

  • Systematic genome-wide screening of signaling pathways.
  • Analysis of BRAF gene mutations in human cancer samples.
  • Functional studies of mutated BRAF proteins in cell lines.

Main Results:

  • BRAF somatic missense mutations found in 66% of malignant melanomas.
  • Mutations predominantly located in the kinase domain, with V599E being the most common (80%).
  • Mutated BRAF proteins exhibit increased kinase activity and transforming potential, independent of RAS signaling.

Conclusions:

  • BRAF is frequently activated by somatic point mutations in human cancers.
  • Activated BRAF kinase presents potential therapeutic targets for malignant melanoma and other cancers.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...